P. Chanez (Montpellier, France), M. O. Hoekstra (Utrecht, The Netherlands)
Immunotherapy as a preventive treatment for new onset asthma? A hospital-based retrospective cohort study
C. Russo, W. K. Al-Delaimy, M. Sarvà, R. Polosa (Catania, Italy; San Diego, United States Of America)
|  |
Confirmed clinical safety and efficacy of grass allergen tablets
S. Rak, A. Stender, R. Dahl (Gothenburg, Sweden; Hørsholm, Aarhus, Denmark)
| |
Specific immunotherapy with high dose grass allergen tablets was safe in grass pollen induced asthma
M. Calderon, A. Stender (London, United Kingdom; Hørsholm, Denmark)
| |
Efficacy and safety of the short term immunotherapy (SIT) in allergic rhinoconjunctivitis (AR)
I. Olcay, Y. Yilmaz, M. Özcan, M. Özcan, A. Ünal (Ankara, Turkey)
| |
Successful heparin desensitization after anaphylactic shock due to low molecular weight heparin
D. Altintas, M. Aybar, A. Topeli, B. Bozkurt, G. Karakaya, F. Kalyoncu (Ankara, Turkey)
| |
ROS generation in monocytes of children with pollinosis
G. Semenkova, A. Krjukov, J. Razumovitch, E. Kavalenka, S. Cherenkevich, M. Petuh, V. Zhernosek, D. Fuchs (Minsk, Belarus; Innsbruck, Austria)
| |
Allergen immunotherapy downregulate CD86 expression on dendritic cells and upregulate CTLA-4 expression on T cells in a mouse asthma model
X. Cheng, C. Wang, G. Qian (Chongqing, China)
| |
Aspirin desensitization
M. Niedoszytko, M. Chelminska, K. Specjalski, E. Jassem (Gdansk, Poland)
| |
Efficacy, safety and tolerability of 3 day azithromycin (A) versus 10-day conventional treatment (CT) in the treatment of children with acute asthma exacerbation (AE)
I. P. Dijana, Z. V. Tatjana, S. Kamenov (Dimitrovgrad, Nis, Serbia And Montenegro)
| |
Effect of an inhaled alpha4-antagonist on the allergen-induced late asthmatic response in patients with mild asthma
A. J. Ravensberg, B. Luijk, P. Westers, B. van den Heuvel, E. Jachtenberg, P. S. Hiemstra, P. J. Sterk, J. W. Lammers, K. F. Rabe (Leiden, Utrecht, Netherlands)
| |
A comparison of oral loratadine and fluticasone propionate aqueous nasal spray plus oral loratadine in the treatment of atopic cough associated with seasonal allergic rhinitis (SAR)
M. D. Filipovic, S. S. Cekic (Nis, Serbia And Montenegro)
| |
Absence of inhibitory effect of levocetirizine on the metabolism of human cytochrome P450 model substrates
J. Nicolas, A. Russel, R. Whomsley, M. Strolin Benedetti, E. Baltes (Braine l‘Alleud, Belgium; Nanterre, France; Edinburgh, United Kingdom)
| |
Is facial thermography sensitive enough to differentiate levocetirizine (LEV) and cetirizine (CET)? A pilot study
M. Larbig, B. Burtin, A. Bruns, L. Martin, J. Hohlfeld, N. Krug (Hannover, Germany; Braine l´Alleud, Belgium)
| |
Efficacy and safety of levocetirizine in persistent allergic rhinitis (PER)
P. Van Cauwenberge, T. X. Study Group (Ghent, Belgium)
| |
Anti-inflammatory and immunomodulatory potential of Cys LT1 receptor antagonists (LTRA) in steroid dependent persistent asthma
T. V. Zaharov (Dimitrovgrad, Serbia And Montenegro)
| |
Treatment of Th2 asthma with lactic acid bacteria
T. V. Zaharov, D. P. Ivanov, S. P. Kamenov, B. A. Kamenov (Dimitrovgrad, Nis, Serbia And Montenegro)
| |
Prednisolone reduces 8-Iso-PGF2alpha in a feline model of asthma
N. Kirschvink, J. Leemans, F. Delvaux, C. Clercx, P. Gustin (Liège, Belgium)
| |
The intervening effects of mycophenolate mofetil on CD34+ hematopoietic cells in bone marrow of asthma mice
H. Mao, K. Yin (Nanjing, China)
| |
Levocetirizine and montelukast in the treatment of seasonal allergic rhinitis
G. Lombardo, P. Quattrocchi, G. R. Lombardo, L. Barresi (Messina, Italy)
| |
Immune regulatory effect of Mycobacterium vaccae vaccine on asthmatic guinea pig
Y. Zhao, X. Wu, Y. Luo (Chongqing, China)
| |